During the corresponding time, Organigram Global Inc recorded a revenue increase by 62.15 % year on year, While revenue at the Organigram Global Inc 's corporate clients
Organigram Global Inc's Comment on Sales, Marketing and Customers
The Company served customers in the United Kingdom, including Avida Medical Limited, a medical cannabis and special medicines manufacturer; however, this relationship was later terminated. It made a strategic investment in Sanity Group to expand its presence in the European cannabis market. The Company also invested in Phylos, acquiring unique auto-flower seed varietals and an expanded genetics license. Additionally, the Company collaborated with BAT through the Product Development Collaboration (PDC) to develop and commercialize FAST™ (Fast Acting Soluble Technology), launching Edison Sonics gummies as the first product utilizing this technology.
Toronto, Canada Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), referred to henceforth as Organigram, has taken a significant step in enhancing its cannabis genetics and seed portfolio. The company, a prominent licensed producer of cannabis, announced today that it has completed an early partial funding of its final third tranche investment into Phylos Bioscience Inc. (Phylos), a U.S.-based cannabis genetics powerhouse and provider of production-ready seeds. This move is particularly strategic, as Organigram aims to bolster its auto-flower and rare cannabinoid offerings, thereby diversifying and enriching its product portfolio.Phylos, renowned for its innovative work in cannabis genetics, has been a key...
Organigram Expands International Presence with Three-Year Supply Agreement in the UKOrganigram Holdings Inc., a renowned licensed producer of cannabis, has recently signed a significant three-year supply agreement with Avida Medical, a leading full-service medical cannabis and specials medicines manufacturer in the UK. This collaboration marks Organigram s second venture into the UK market and is poised to strengthen the company s international foothold.Under the terms of the agreement, Organigram expects to supply Avida Medical with a substantial 1,700 kilograms of premium, indoor-grown dried cannabis flower. This high-quality product will serve the rapidly growing demand for medical cannabis in the UK, ens...
TORONTO - Organigram Holdings Inc. (Organigram) a major player on The Toronto Stock Exchange and NASDAQ, announced on January 18, 2024, the outcomes of its annual general and special meeting of shareholders held virtually. A clear highlight of the gathering was the approval of an impressive C$124.6 million investment from British American Tobacco (BAT).The move manifests as a power play in the highly competitive cannabis industry, putting Organigram at a distinct advantage. The BAT resources are expected to not just fortify Organigram s financial muscle, but also to enhance its research and development capabilities across the globe. As per the details shared during Organigram s annual general and special m...
Organigram Global Inc’s Comment on Sales, Marketing and Customers
The Company served customers in the United Kingdom, including Avida Medical Limited, a medical cannabis and special medicines manufacturer; however, this relationship was later terminated. It made a strategic investment in Sanity Group to expand its presence in the European cannabis market. The Company also invested in Phylos, acquiring unique auto-flower seed varietals and an expanded genetics license. Additionally, the Company collaborated with BAT through the Product Development Collaboration (PDC) to develop and commercialize FAST™ (Fast Acting Soluble Technology), launching Edison Sonics gummies as the first product utilizing this technology.
Sources:
Organigram Global Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Organigram Global Inc’s corporate clients.
For your research, we’ve provided 9 tables on Organigram Global Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
140.75 %